Seventeen clinical scenarios developed for which amyloid or tau PET may be considered. HealthDay News — Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) ...
On July 13, 2021, the Centers for Medicare and Medicaid Services (CMS) released the calendar year (CY) 2022 proposed changes to the physician fee schedule. CMS devoted 25 pages of the proposed rule to ...
The appropriate application of transthoracic echocardiography (TTE) and other cardiac imaging modalities is a cornerstone of modern cardiological practice. By integrating evidence-based guidelines ...
Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the Alzheimer's Association and the Society for Nuclear Medicine and Molecular ...
The American College of Cardiology (ACC), together with nine other professional societies, has released new appropriate use criteria (AUC) for a range of cardiovascular imaging modalities. The hope, ...
Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...
Reston, VA—The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic ...
An expert workgroup has developed the first appropriate use recommendations (AURs) for real-world use of the antiamyloid donanemab (Kisunla). “The role of appropriate use recommendations are to bridge ...
Monash University publishes a world first clinical practice guideline for the appropriate use of psychedelics; Monash University publishes a w ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results